Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2010-09-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2010.07.071PMID 20728366PMCID PMC2934896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structures of human proteinase 3 and neutrophil elastase – so similar yet so different

  2010cited by this paper
• The Protective Function of Neutrophil Elastase Inhibitor in Liver Ischemia/Reperfusion Injury

  2010cited by this paper
• Neutrophil Elastase-Mediated Degradation of IRS-1 Accelerates Lung Tumor Growth

  2010cited by this paper
• Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development

  2009cited by this paper
• Mechanism-based inhibitors of serine proteases with high selectivity through optimization of S' subsite binding.

  2009cited by this paper
• Burden and pathogenesis of chronic obstructive pulmonary disease.

  2009cited by this paper
• Human neutrophil elastase: mediator and therapeutic target in atherosclerosis.

  2008cited by this paper
• Neutrophil elastase activity in acute lung injury and respiratory distress syndrome

  2008cited by this paper
• Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.

  2008cited by this paper
• Inhibition of airway proteases in cystic fibrosis lung disease

  2008cited by this paper
• Proteases and cystic fibrosis.

  2008cited by this paper
• Molecular pathogenesis of emphysema.

  2008cited by this paper
• X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives.

  2008cited by this paper
• Emerging pharmacotherapies for COPD.

  2008cited by this paper
• Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.

  2008cited by this paper
• Epithelial responses to oxidative stress in chronic obstructive pulmonary disease: lessons from expression profiling.

  2007cited by this paper
• The behavior and significance of slow-binding enzyme inhibitors.

  2006cited by this paper
• Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema

  2006cited by this paper
• Emerging drugs for the treatment of chronic obstructive pulmonary disease

  2006cited by this paper
• Neutrophil elastase: mediator of extracellular matrix destruction and accumulation.

  2006cited by this paper
• Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.

  2005cited by this paper
• The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years.

  2005cited by this paper
• Mechanism-based inactivation of human leukocyte elastase via an enzyme-induced sulfonamide fragmentation process.

  2004cited by this paper
• Respiratory Research BioMed Central Review

  2004cited by this paper
• Alveolar wall apoptosis causes lung destruction and emphysematous changes.

  2003cited by this paper
• Apoptosis and emphysema: the missing link.

  2003cited by this paper
• Clinical research in chronic obstructive pulmonary disease: needs and opportunities.

  2003cited by this paper
• Proteases and lung injury

  2003cited by this paper
• Compared Action of Neutrophil Proteinase 3 and Elastase on Model Substrates

  2003cited by this paper
• 1,2,5-Thiadiazolidin-3-one 1,1 dioxide: a powerful scaffold for probing the S' subsites of (chymo)trypsin-like serine proteases.

  2001cited by this paper
• Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold.

  2001cited by this paper
• Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates.

  2000cited by this paper
• A General Inhibitor Scaffold for Serine Proteases with a (Chymo)trypsin-Like Fold: Solution-Phase Construction and Evaluation of the First Series of Libraries of Mechanism-Based Inhibitors

  1999cited by this paper
• Inflammation and repair processes in chronic obstructive pulmonary disease.

  1999cited by this paper
• Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.

  1997cited by this paper
• The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.

  1996cited by this paper
• Searching for Minimum Increments of Hydrophobic Collapse: Flexible Dinaphthyl Carboxylates

  1995cited by this paper
• Importance of parallel vectors and "hydrophobic collapse" of the aligned aromatic rings: discovery of a potent substance P antagonist.

  1994cited by this paper
• New mechanism-based inactivators of trypsin-like proteinases. Selective inactivation of urokinase by functionalized cyclopeptides incorporating a sulfoniomethyl-substituted m-aminobenzoic acid residue.

  1993cited by this paper
• Hydrophobic collapse of taxol and taxotere solution conformations in mixtures of water and organic solvent

  1993cited by this paper
• Peptidomimetics derived from natural products

  1993cited by this paper
• On the size of the active site in proteases. I. Papain.

  1967cited by this paper

• 1,2,5-Thiadiazoles

  2020cites this paper
• Diastereo- and enantioselective Mannich/cyclization cascade reaction of isocyanoacetates with cyclic sulfamide ketimines by cinchona alkaloid squaramide/AgOAc cooperative catalysis.

  2018cites this paper
• Enantioselective aza-Friedel-Crafts reaction of cyclic ketimines with indoles using chiral imidazoline-phosphoric acid catalysts.

  2018cites this paper
• Simple Open-Chain Phosphite-Olefin as Ligand for Rh-Catalyzed Asymmetric Arylation of Cyclic Ketimines: Enantioselective Access to gem-Diaryl α-Amino Acid Derivatives

  2016cites this paper
• Neutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors.

  2012cites this paper